Anti-STAT1 (phospho Y701) antibody
3
(6 Reviews)
|
(61 Publications)
Rabbit Polyclonal STAT1 phospho Y701 antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 61 publications. Immunogen corresponding to Synthetic Peptide within Human STAT1 phospho Y701.
View Alternative Names
Signal transducer and activator of transcription 1-alpha/beta, Transcription factor ISGF-3 components p91/p84, STAT1
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-STAT1 (phospho Y701) antibody (AB30645)
ICC/IF image of ab30645 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab30645, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-STAT1 (phospho Y701) antibody (AB30645)
Paraffin-embedded human breast carcinoma tissue stained for STAT1 (phospho Y701) using ab30645 at 1/590 dilution in immunohistochemical analysis. Tissue was incubated in the absence (left) or presence (right) of immunizing phospho-peptide.
- IHC-P
AbReview31171****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-STAT1 (phospho Y701) antibody (AB30645)
ab30645 staining STAT1 (phospho Y701) in murine intestine tissue by Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections).
Tissue was fixed with paraformaldehyde and blocked with 5% serum for 1 hour at 23°C; antigen retrieval was by heat mediation with a citrate buffer. Samples were incubated with primary antibody (1/400 in Tris Buffer Saline) for 16 hours at 4°C. An AlexaFluor®488-conjugated goat anti-rabbit polyclonal IgG (1/200) was used as the secondary antibody.
This image is courtesy of an anonymous Abreview
- WB
Unknown
Western blot - Anti-STAT1 (phospho Y701) antibody (AB30645)
Suggested dilution : 1 : 500 - 1 : 1000
All lanes:
Western blot - Anti-STAT1 (phospho Y701) antibody (ab30645)
Lane 1:
Untreated MCF7 lysate (5-30ug).
Lane 2:
EGF treated MCF7 lysate (5-30ug).
Predicted band size: 87 kDa
Observed band size: 47 kDa,87 kDa
false
- WB
CiteAb
Western blot - Anti-STAT1 (phospho Y701) antibody (AB30645)
STAT1 (phospho Y701) western blot using anti-STAT1 (phospho Y701) antibody ab30645. Publication image and figure legend from Qiu, X., Fu, Q., et al., 2016, PLoS One, PubMed 26859759.
ab30645 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab30645 please see the product overview.
Newcastle disease virus infection impaired IFN-α-induced STAT1 phosphorylation.(A) IFN-α-induced phosphorylated STAT1 degradation in NDV-infected A549 and Vero cells. A549 or Vero cells were infected with NDV strains ZJ1 at MOI 3. At indicated time points post infection, A549 and Vero cells were stimulated with 500 U/ml human IFN-α or IFN-γ in 1 ml DMEM at 37°C for 15 min. Uninfected cells were stimulated with IFN as negative controls (IFNα+/infection-). IFN-α-induced phospho-STAT1 was observed (IFNα+/infection+) for reduction in total STAT1 proteins. IFN-γ-induced phospho-STAT1 proteins were not reduced. (B) Phospho-STAT1 in A549 cells transfected with V-expressing plasmids after stimulation with IFN-α. (C) Expression level of STAT1 and phospho-STAT1 decreased in V-expressing Vero cells after IFN-α stimulation. Vero cells were mock transfected with pCI-neo plasmids. Cells on glass coverlips were transfected with pCI-V/ZJ1 plasmids. At 48 h post-transfection, cells were treated with IFN-α for 15 min prior to fixation as in “Material and methods”. V protein was detected by a mixture of anti-serum Pab-V1 and Pab-V2; STAT1 and phosphorylation were determined by anti-STAT1 antibody (ab31369) and anti-phospho-STAT1 antibody (ab30645). Cellular nuclei were stained with DAPI.
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The STAT1 protein influences cell survival and immune responses. It functions as a transcription factor and participates in the interferon signaling pathway. In this setting it forms a complex with other STAT proteins such as STAT2 and STAT3 to regulate gene expression. By binding to specific DNA sequences in the nucleus STAT1 alters transcription in response to extracellular signals. It contributes to antiviral defense mechanisms and antiproliferative activities in various cells.
Pathways
The STAT1 protein plays essential roles in the JAK-STAT signaling pathway and interferon signaling pathway. It operates closely with proteins such as JAK1 and TYK2 which are involved in the phosphorylation process activating STAT1. During this activation STAT1 helps initiate cellular responses to interferons a type of signaling protein released during viral infections. The JAK-STAT pathway facilitates various physiological processes including immune responses and cell growth regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (61)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 16:231 PubMed40169556
2025
Applications
Unspecified application
Species
Unspecified reactive species
Analytical cellular pathology (Amsterdam) 2024:6624283 PubMed39624161
2024
Applications
Unspecified application
Species
Unspecified reactive species
EMBO molecular medicine 16:3142-3168 PubMed39521937
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 15:608 PubMed39168971
2024
Applications
Unspecified application
Species
Unspecified reactive species
Immunology 172:469-485 PubMed38544333
2024
Applications
Unspecified application
Species
Unspecified reactive species
Brain research bulletin 208:110889 PubMed38290590
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:438 PubMed38200007
2024
Applications
Unspecified application
Species
Unspecified reactive species
BMC veterinary research 19:270 PubMed38087313
2023
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 13:5218-5235 PubMed38058799
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research : CR 42:194 PubMed37542342
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com